Suppr超能文献

长期药物治疗联合间歇性清洁导尿对神经源性逼尿肌过度活动症患儿的影响。

The effects of long-term medical treatment combined with clean intermittent catheterization in children with neurogenic detrusor overactivity.

机构信息

Department of Pediatric Surgery, University of Leipzig, Leipzig, Germany.

出版信息

Int Urol Nephrol. 2012 Apr;44(2):335-41. doi: 10.1007/s11255-011-0030-y. Epub 2011 Jul 21.

Abstract

OBJECTIVES

To assess whether conservative treatment of pediatric patients with neurogenic detrusor overactivity (NDO) results in lower bladder pressure and increased expected bladder volume (EBV), we investigated the clinical and urodynamic effects of long-term intravesical oxybutynin instillation compared with a standard treatment of oral anticholinergic medication in patients with clean intermittent catheterization (CIC).

METHODS

A retrospective study was performed including 21 patients suffering from myelomeningocele and NDO. Initially, all patients were treated with oral anticholinergics and CIC. Ten of the 21 patients showed a sufficient response to the treatment and were included in group I (anticholinergics and CIC). The other 11 patients responded poorly to the initial treatment or developed side effects to oral medication. These patients were included in group II and treated with intravesical oxybutynin and CIC. The two groups were compared using clinical, sonographic and urodynamic examinations performed prior to starting treatment and repeated on an annual basis. Changes from baseline were analyzed with the Mann-Whitney U test.

RESULTS

Ten patients in group I and 11 in group II were investigated. Two of the 11 patients in group II stopped the treatment. The mean starting age was 8.1 (± 6.6) years in group I and 12.5 (± 4.5) years in group II. The mean follow-up time was 7.1 (± 5.5) years in group I and 3.6 (± 1.8) years in group II. Bladder capacity increased from 173 (± 99) to 371 (± 115) ml in group I and from 245 (± 133) to 370 (± 156) ml in group II. Six of the 10 patients in group I and 6/9 patients in group II reached normal EBV. Three of the 10 subjects in group I and 6/9 in group II had bladder compliance values >10 ml/cm H(2)O. At final follow-up, the overall rate of urinary tract infections was equal. Social continence was achieved in 6/10 in group I and 7/9 in group II. Altogether, 19/21 patients responded to conservative management.

CONCLUSIONS

In children with NDO, conservative medical treatment combined with CIC is feasible and provides an improved pattern of bladder function, which could help avoid bladder surgery.

摘要

目的

为了评估对神经源性逼尿肌过度活动(NDO)的儿科患者进行保守治疗是否会降低膀胱压力并增加预期膀胱容量(EBV),我们研究了与清洁间歇导尿(CIC)相比,长期膀胱内奥昔布宁灌注对临床和尿动力学的影响,在接受 CIC 的患者中,奥昔布宁灌注用于口服抗胆碱能药物的标准治疗。

方法

进行了一项回顾性研究,纳入 21 例患有脊髓脊膜膨出和 NDO 的患者。最初,所有患者均接受口服抗胆碱能药物和 CIC 治疗。21 例患者中有 10 例对治疗有足够反应,被纳入组 I(抗胆碱能药物和 CIC)。其他 11 名患者对初始治疗反应不佳或出现口服药物的副作用。这些患者被纳入组 II 并接受膀胱内奥昔布宁和 CIC 治疗。两组均采用临床、超声和尿动力学检查进行评估,在开始治疗前和每年重复一次。采用 Mann-Whitney U 检验分析从基线的变化。

结果

组 I 中有 10 例患者,组 II 中有 11 例患者。组 II 中有 2 例患者停止治疗。组 I 的平均起始年龄为 8.1(±6.6)岁,组 II 为 12.5(±4.5)岁。组 I 的平均随访时间为 7.1(±5.5)年,组 II 为 3.6(±1.8)年。组 I 中膀胱容量从 173(±99)ml 增加到 371(±115)ml,组 II 中膀胱容量从 245(±133)ml 增加到 370(±156)ml。组 I 中有 6/10 例患者和组 II 中有 6/9 例患者达到正常 EBV。组 I 中有 3 例患者和组 II 中有 6/9 例患者的膀胱顺应性值>10 ml/cm H2O。最终随访时,尿路感染的总体发生率相同。组 I 中有 6/10 例患者和组 II 中有 7/9 例患者获得社会控尿。共有 21 例患者中的 19 例对保守治疗有反应。

结论

在患有 NDO 的儿童中,联合 CIC 的保守药物治疗是可行的,并且可以改善膀胱功能模式,从而有助于避免膀胱手术。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验